GB9712892D0 - Identification of mhc binding peptides - Google Patents

Identification of mhc binding peptides

Info

Publication number
GB9712892D0
GB9712892D0 GBGB9712892.0A GB9712892A GB9712892D0 GB 9712892 D0 GB9712892 D0 GB 9712892D0 GB 9712892 A GB9712892 A GB 9712892A GB 9712892 D0 GB9712892 D0 GB 9712892D0
Authority
GB
United Kingdom
Prior art keywords
identification
binding peptides
mhc binding
mhc
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9712892.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biovation Ltd
Original Assignee
Biovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovation Ltd filed Critical Biovation Ltd
Priority to GBGB9712892.0A priority Critical patent/GB9712892D0/en
Publication of GB9712892D0 publication Critical patent/GB9712892D0/en
Priority to AU81183/98A priority patent/AU8118398A/en
Priority to PCT/GB1998/001801 priority patent/WO1998059244A1/en
Pending legal-status Critical Current

Links

GBGB9712892.0A 1997-06-20 1997-06-20 Identification of mhc binding peptides Pending GB9712892D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9712892.0A GB9712892D0 (en) 1997-06-20 1997-06-20 Identification of mhc binding peptides
AU81183/98A AU8118398A (en) 1997-06-20 1998-06-19 Identification of mhc binding peptides
PCT/GB1998/001801 WO1998059244A1 (en) 1997-06-20 1998-06-19 Identification of mhc binding peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9712892.0A GB9712892D0 (en) 1997-06-20 1997-06-20 Identification of mhc binding peptides

Publications (1)

Publication Number Publication Date
GB9712892D0 true GB9712892D0 (en) 1997-08-20

Family

ID=10814539

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9712892.0A Pending GB9712892D0 (en) 1997-06-20 1997-06-20 Identification of mhc binding peptides

Country Status (3)

Country Link
AU (1) AU8118398A (en)
GB (1) GB9712892D0 (en)
WO (1) WO1998059244A1 (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062832A2 (en) * 2001-02-06 2002-08-15 Merck Patent Gmbh Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity
DE60227367D1 (en) 2001-02-06 2008-08-14 Merck Patent Gmbh MODIFIED GRANULOCYTE STIMULATING FACTOR (G-CSF) WITH REDUCED IMMUNOGENITY
CA2439926A1 (en) 2001-03-08 2002-09-12 Merck Patent Gesellschaft Mit Beschraenkter Haftung Modified human granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity
PL369309A1 (en) * 2001-03-20 2005-04-18 Merck Patent Gmbh Modified insulin with reduced immunogenicity
WO2002079415A2 (en) 2001-03-30 2002-10-10 Lexigen Pharmaceuticals Corp. Reducing the immunogenicity of fusion proteins
WO2003020761A1 (en) * 2001-09-04 2003-03-13 Merck Patent Gmbh Modified human growth hormone
EP1495052B9 (en) * 2002-04-18 2009-12-16 MERCK PATENT GmbH Modified factor viii
DE60312330T2 (en) * 2002-06-10 2007-11-22 Algonomics N.V. METHOD FOR PREDICTING THE BINDING SAFFINITY OF MHC PEPTIDE COMPLEXES
US20090010920A1 (en) 2003-03-03 2009-01-08 Xencor, Inc. Fc Variants Having Decreased Affinity for FcyRIIb
US7610156B2 (en) 2003-03-31 2009-10-27 Xencor, Inc. Methods for rational pegylation of proteins
EP1610825A2 (en) 2003-03-31 2006-01-04 Xencor, Inc. Methods for rational pegylation of proteins
US7642340B2 (en) 2003-03-31 2010-01-05 Xencor, Inc. PEGylated TNF-α variant proteins
US8399618B2 (en) 2004-10-21 2013-03-19 Xencor, Inc. Immunoglobulin insertions, deletions, and substitutions
US8883147B2 (en) 2004-10-21 2014-11-11 Xencor, Inc. Immunoglobulins insertions, deletions, and substitutions
US9714282B2 (en) 2003-09-26 2017-07-25 Xencor, Inc. Optimized Fc variants and methods for their generation
BRPI0416141B8 (en) 2003-11-01 2021-05-25 Biovation Ltd modified anti-cd52 antibody, pharmaceutical composition, expression vectors, and method of preparing an immunoglobulin
CA2548817A1 (en) 2003-12-04 2005-06-23 Xencor, Inc. Methods of generating variant proteins with increased host string content and compositions thereof
WO2005070967A2 (en) 2004-01-22 2005-08-04 Merck Patent Gmbh Anti-cancer antibodies with reduced complement fixation
EP1737890A2 (en) 2004-03-24 2007-01-03 Xencor, Inc. Immunoglobulin variants outside the fc region
EP1919950A1 (en) 2004-07-15 2008-05-14 Xencor, Inc. Optimized fc variants
KR101027427B1 (en) 2004-11-12 2011-04-11 젠코어 인코포레이티드 Fc VARIANTS WITH INCREASED BINDING TO FcRn
US8367805B2 (en) 2004-11-12 2013-02-05 Xencor, Inc. Fc variants with altered binding to FcRn
US8802820B2 (en) 2004-11-12 2014-08-12 Xencor, Inc. Fc variants with altered binding to FcRn
FI20060200A0 (en) * 2005-04-20 2006-02-27 Glykos Finland Oy Method for analyzing the specificity of sialic acid binding of human influenza virus
WO2007041635A2 (en) 2005-10-03 2007-04-12 Xencor, Inc. Fc variants with optimized fc receptor binding properties
CN101351477B (en) 2005-12-30 2011-11-16 默克专利有限公司 Anti-CD19 antibodies with reduced immunogenicity
US20070192033A1 (en) 2006-02-16 2007-08-16 Microsoft Corporation Molecular interaction predictors
US8396671B2 (en) 2006-02-16 2013-03-12 Microsoft Corporation Cluster modeling, and learning cluster specific parameters of an adaptive double threading model
US8706421B2 (en) 2006-02-16 2014-04-22 Microsoft Corporation Shift-invariant predictions
EP2062180A2 (en) * 2006-08-25 2009-05-27 The Government of the United States of America as Represented by The Department of Health and Human Services Epitope-protein scaffolds and their use
US8121797B2 (en) 2007-01-12 2012-02-21 Microsoft Corporation T-cell epitope prediction
MX2009013635A (en) 2007-06-25 2010-05-19 Univ Tulane Influenza inhibiting compositions and methods.
EP2296688A2 (en) * 2007-10-26 2011-03-23 Glykos Finland Oy Peptide vaccine for influenza virus
SI2235059T1 (en) 2007-12-26 2015-06-30 Xencor, Inc. Fc variants with altered binding to fcrn
WO2011028952A1 (en) 2009-09-02 2011-03-10 Xencor, Inc. Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
WO2011119484A1 (en) * 2010-03-23 2011-09-29 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
EP2471543A1 (en) 2010-12-02 2012-07-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Tolerance induction or immunosupression to prevent in particular Graft-versus-Host-Disease (GvHD) by short-term pre-incubation of transplanted cell suspensions, tissues or organs coated with ligands to cell surface molecules
GB201103955D0 (en) 2011-03-09 2011-04-20 Antitope Ltd Antibodies
GB201109238D0 (en) 2011-06-01 2011-07-13 Antitope Ltd Antibodies
US9988439B2 (en) 2011-12-23 2018-06-05 Nicholas B. Lydon Immunoglobulins and variants directed against pathogenic microbes
WO2013096948A1 (en) 2011-12-23 2013-06-27 Lydon Nicholas B Immunoglobulins and variants directed against pathogenic microbes
EP3539563A1 (en) 2012-07-19 2019-09-18 Redwood Bioscience, Inc. Antibody specific for cd22 and methods of use thereof
CN104994874B (en) 2012-12-26 2017-04-12 安科协同公司 ANTI- INTEGRIN [beta]1 ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824315A (en) * 1993-10-25 1998-10-20 Anergen, Inc. Binding affinity of antigenic peptides for MHC molecules
AU701302B2 (en) * 1994-05-13 1999-01-21 Merck Patent Gesellschaft Mit Beschrankter Haftung Improvements in or relating to peptide delivery

Also Published As

Publication number Publication date
WO1998059244A1 (en) 1998-12-30
AU8118398A (en) 1999-01-04

Similar Documents

Publication Publication Date Title
GB9712892D0 (en) Identification of mhc binding peptides
EP0888120A4 (en) Hla binding peptides and their uses
EP1080182A4 (en) Amino acid modified polypeptides
GB9718110D0 (en) Peptides
GB9714276D0 (en) Peptides and related compounds
GB9700154D0 (en) Peptides
ZA984322B (en) Sucrose-binding proteins
EP0996457A4 (en) Fsh-releasing peptides
GB9723006D0 (en) Material identification
IL131496A0 (en) Modified retinoblastoma tumor suppressor proteins
GB9613705D0 (en) Novel peptides
GB9721422D0 (en) Identification system
GB9706380D0 (en) Binding mixtures
GB9604865D0 (en) Modified proteins
GB9713146D0 (en) Peptides
GB9706556D0 (en) Peptides
GB9701024D0 (en) Peptides
GB9707499D0 (en) Proteins
GB9722727D0 (en) Proteins
GB9722003D0 (en) Proteins
GB9707822D0 (en) Proteins
GB9700121D0 (en) Proteins
IL120413A0 (en) Novel PKA-binding proteins and uses thereof
IL120392A0 (en) Novel PKA-binding proteins and uses thereof
GB9706119D0 (en) Novel protein